Gordon Carmichael
Insider
First SEC filing: June 30, 2026 · Latest: June 30, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 10, 2026 | GYRE | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 4, 2025 | GYRE | A | 26,000 | · | · | 26,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 14, 2024 | GYRE | A | 52,000 | · | · | 52,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 31, 2023 | GYRE | A | 1,866 | · | · | 1,866 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 10, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock | $5.95 | June 10, 2036 | 40,000 | Acquired |
| June 4, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock | $8.58 | June 4, 2035 | 26,000 | Acquired |
| Aug. 14, 2024 | GYRE | Stock Option (Right to Buy) | Common Stock | $9.98 | Aug. 14, 2034 | 52,000 | Acquired |
| Oct. 31, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock | $6.93 | Oct. 31, 2033 | 1,866 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).